NOW:53208:USA01012
http://widgets.journalinteractive.com/cache/JIResponseCacher.ashx?duration=5&url=http%3A%2F%2Fdata.wp.myweather.net%2FeWxII%2F%3Fdata%3D*USA01012
82°
H 88° L 63°
Clear | 12MPH

Enzyme Replacement Therapy Shows Promising Results in X-Linked Myotubular Myopathy

Jan. 24, 2013

A collaborative research team including a Medical College of Wisconsin (MCW) pediatric neuropathologist successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy from 4s3 Bioscience.

The findings are published in the January edition of Human and Molecular Genetics http://hmg.oxfordjournals.org/content/early/2013/01/09/hmg.ddt003.full.pdf+html.

X-linked myotubular myopathy (XLMTM) is a severe muscle disease caused by an absence of a protein called myotubularin. There is currently no treatment for this disorder, and most patients die in infancy or childhood. The overall incidence of myotubular myopathy is 1 in 50,000 live male births.

Michael W. Lawlor, MD, PhD, assistant professor of pathology at MCW, researcher at the Children’s Hospital of Wisconsin Research Institute, and director of the pediatric pathology neuromuscular laboratory in MCW’s division of pediatric pathology, coordinated a study at Boston Children’s Hospital and MCW that used targeted enzyme replacement therapy to deliver myotubularin to muscles of mice with XLMTM. After two weeks of treatment, the mice showed marked improvement in muscle function and pathology.

“These promising findings suggest that even low levels of myotubularin protein replacement can not only improve weakness in patients, but also at least partially reverse the structural abnormalities seen in XLMTM,” said Dr. Lawlor. “The next step is to determine appropriate dosage, and toxicity, before we venture into human trials,” he continued.

The study was supported by the National Institutes of Health, the Muscular Dystrophy Association, the Joshua Frase Foundation, and the Lee and Penny Anderson Family Foundation.

Co-authors of the study are Dustin Armstrong and Michael O’Callaghan from 4s3 Bioscience, Inc.; Marissa Viola, Cynthia P. Hsu, and Alan H. Beggs from Boston Children’s Hospital and Harvard Medical School; Jeffrey J. Widrick from Spaulding Rehabilitation Hospital; Hui Meng from MCW; Robert W. Grange from Virginia Tech; Martin Childers from Wake Forest University; Christopher R. Pierson from Nationwide Children’s Hospital; and Anna Buj-Bello from INSERM.

The efforts of Drs. Armstrong, Beggs, and Lawlor began while Dr. Lawlor was working for Dr. Beggs at Boston Children’s Hospital, and this collaborative effort has continued at Dr. Lawlor’s lab at MCW. As studies progress, Dr. Lawlor will continue to perform pathological analyses on research tissue from preclinical studies with the 4s3 Bioscience replacement enzyme and assist in further elucidating the pathophysiology of XLMTM. This work by Dr. Lawlor’s laboratory utilizes resources partially supported and available through the Children’s Research Institute’s Imaging Core Facility.

This site uses Facebook comments to make it easier for you to contribute. If you see a comment you would like to flag for spam or abuse, click the "x" in the upper right of it. By posting, you agree to our Terms of Use.

Suburban News Roundup

E-mail Newsletter

Your link to the biggest stories in the suburbs delivered Thursday mornings.


Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter
Get the Newsletter!

Login or Register to manage all your newsletter preferences.

Community Watch

» Annual 'Tosa's Night Out' is Aug. 4 at Hart Park 11:53 AM

» 'Milwaukee lion' spotted in Glendale Updated:  11:45 AM

» Mayfair holds back-to-school style event 10:14 AM

» Medical College of Wisconsin construction begins Aug. 3 7/24

» Therapy program's art gallery opening is this weekend 7/22

» The Suburban 16 Power Rankings: Watt, Niebrugge, and others on the next level 7/22

» The Landing at Hoyt Park has become destination for local musicians 7/22

» Wauwatosa West loses pitchers' duel to Pius in regional semifinal 7/22

» Where did the summer go? 7/22

» Sports Notes: July 23, 2015 7/22

» Pewaukee's fast start ends Wauwatosa East baseball team's season 7/22

» Initial Reaction Podcast: A dumb-sports-fan's guide to the Bucks arena financing situation 7/21

» Upcoming Wauwatosa meeting to discuss housing for people with disabilities 7/21

» Milwaukee Co. Zoo gains two snow leopards 7/20

» Meijer announces $25,000 donation to Wauwatosa Library 7/20

» Man shot, killed by Wauwatosa police was brandishing sword Updated:  7/18

» Wauwatosa early learning program to begin this fall 7/17

» GoPro perspective: Inside a firefighter training burn in Wauwatosa 7/17

» Chief Weber: Wauwatosa man killed by police was carrying sword, given 'numerous commands' to put down weapon 7/17

» One person dead after police-involved shooting in Wauwatosa Updated:  7/17

» Milwaukee Co. Zoo adds lactation stations for nursing mothers and babies 7/16

» Greenfield's Bella Matthias headlines the 2015 All-Suburban Softball Team 7/16

» Joe Bartolotta asks Wauwatosa not to grant him $9.5K to offset liquor license cost 7/16

» Take two: Fish Cheeks plans to open this winter in Wauwatosa 7/15

» Wauwatosa nearly out of licenses to allow new businesses to serve liquor 7/15

View All Posts Got a tip? Welcome rss

Advertisement

Advertisement

Hidden Tosa

 

"Hidden Tosa" is a semi-regular feature where reporter Rory Linnane explores the closed down and closed off parts of Wauwatosa.

2015 Writing Contest

 

(Click image for details)

Advertisement

Local Business Directory

CONNECT